These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31113002)

  • 61. Adult-Onset Genetic Leukoencephalopathies. Focus on the More Recently Defined Forms.
    Di Donato I; Banchi S; Federico A; Dotti MT
    Curr Mol Med; 2014; 14(8):944-958. PubMed ID: 25323877
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
    Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
    Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Novel mutations in the GJC2 gene associated with Pelizaeus-Merzbacher-like disease.
    Owczarek-Lipska M; Mulahasanovic L; Obermaier CD; Hörtnagel K; Neubauer BA; Korenke GC; Biskup S; Neidhardt J
    Mol Biol Rep; 2019 Aug; 46(4):4507-4516. PubMed ID: 31270756
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Axonal damage in leukodystrophies.
    Mar S; Noetzel M
    Pediatr Neurol; 2010 Apr; 42(4):239-42. PubMed ID: 20304325
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Leukodystrophies: pathogenesis, diagnosis, strategies, therapies, and future research directions.
    Maria BL; Deidrick KM; Moser H; Naidu S
    J Child Neurol; 2003 Sep; 18(9):578-90. PubMed ID: 14572135
    [No Abstract]   [Full Text] [Related]  

  • 66. Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study.
    Depienne C; Bugiani M; Dupuits C; Galanaud D; Touitou V; Postma N; van Berkel C; Polder E; Tollard E; Darios F; Brice A; de Die-Smulders CE; Vles JS; Vanderver A; Uziel G; Yalcinkaya C; Frints SG; Kalscheuer VM; Klooster J; Kamermans M; Abbink TE; Wolf NI; Sedel F; van der Knaap MS
    Lancet Neurol; 2013 Jul; 12(7):659-68. PubMed ID: 23707145
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Emerging cellular themes in leukodystrophies.
    Nowacki JC; Fields AM; Fu MM
    Front Cell Dev Biol; 2022; 10():902261. PubMed ID: 36003149
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Leukodystrophies: clinical aspects and findings with computerized tomography and magnetic resonance imaging].
    Magnaldi S
    Radiol Med; 1991; 82(1-2):13-26. PubMed ID: 1896564
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gene therapy in metachromatic leukodystrophy.
    Sevin C; Cartier-Lacave N; Aubourg P
    Int J Clin Pharmacol Ther; 2009; 47 Suppl 1():S128-31. PubMed ID: 20040324
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The leukodystrophies.
    Gordon HB; Letsou A; Bonkowsky JL
    Semin Neurol; 2014 Jul; 34(3):312-20. PubMed ID: 25192509
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Novel therapies in neurometabolic diseases: the importance of early intervention].
    Gutierrez-Solana LG
    Rev Neurol; 2017 May; 64(s03):S25-S28. PubMed ID: 28524215
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MRI appearances of metachromatic leukodystrophy.
    Faerber EN; Melvin J; Smergel EM
    Pediatr Radiol; 1999 Sep; 29(9):669-72. PubMed ID: 10460327
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Glial progenitor cell-based treatment of the childhood leukodystrophies.
    Osorio MJ; Goldman SA
    Exp Neurol; 2016 Sep; 283(Pt B):476-88. PubMed ID: 27170209
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current Therapeutic Approaches in Leukodystrophies: A Review.
    Gordon-Lipkin E; Fatemi A
    J Child Neurol; 2018 Nov; 33(13):861-868. PubMed ID: 30112967
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pelizaeus-Merzbacher-Like disease presentation of MCT8 mutated male subjects.
    Vaurs-Barrière C; Deville M; Sarret C; Giraud G; Des Portes V; Prats-Viñas JM; De Michele G; Dan B; Brady AF; Boespflug-Tanguy O; Touraine R
    Ann Neurol; 2009 Jan; 65(1):114-8. PubMed ID: 19194886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Canavan disease: a white matter disorder.
    Kumar S; Mattan NS; de Vellis J
    Ment Retard Dev Disabil Res Rev; 2006; 12(2):157-65. PubMed ID: 16807907
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Some thoughts on the neurobiology of the leukodystrophies.
    Norton WT
    Neuropediatrics; 1984 Sep; 15 Suppl():28-31. PubMed ID: 6100796
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Immune response in leukodystrophies.
    Eichler F; Van Haren K
    Pediatr Neurol; 2007 Oct; 37(4):235-44. PubMed ID: 17903666
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adrenoleukodystrophy - neuroendocrine pathogenesis and redefinition of natural history.
    Kemp S; Huffnagel IC; Linthorst GE; Wanders RJ; Engelen M
    Nat Rev Endocrinol; 2016 Oct; 12(10):606-15. PubMed ID: 27312864
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment options for lysosomal storage disorders: developing insights.
    van Gelder CM; Vollebregt AA; Plug I; van der Ploeg AT; Reuser AJ
    Expert Opin Pharmacother; 2012 Nov; 13(16):2281-99. PubMed ID: 23009070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.